|
Analysisa
|
Sample size per group
|
ΔC (95% CI)
|
ΔE (95% CI)
| |
Distribution in cost-effectiveness plane (%)
|
---|
| |
Control
|
Intervention
|
Euros
| |
ICER
|
NEb
|
SEc
|
SWd
|
NWe
|
---|
T2DM risk
f
|
Base case
|
300
|
305
|
−866 (-2372;370)
|
0.6 (-0.1;1.3)
|
-1416
|
0.6
|
4.1
|
85.9
|
9.4
|
Complete cases
|
117
|
105
|
−30 (-2171;1446)
|
0.7 (-0.4;1.7)
|
-44
|
5.1
|
4.4
|
45.0
|
45.5
|
|
Health care perspective
|
300
|
305
|
−5 (-316;272)
|
0.6 (-0.1;1.3)
|
−8
|
2.2
|
2.4
|
47.5
|
47.9
|
CVD risk
g
|
Base case
|
300
|
305
|
−866 (-2372;370)
|
−0.1 (-0.4;0.2)
|
6405
|
8.0
|
74.3
|
15.4
|
2.3
|
Complete cases
|
116
|
104
|
−19 (-2253;1410)
|
−0.03 (-0.34;0.29)
|
642
|
29.5
|
27.8
|
21.3
|
21.5
|
|
Health care perspective
|
300
|
305
|
−5 (-316;272)
|
−0.1 (-0.4;0.2)
|
38
|
40.1
|
42.4
|
8.0
|
9.5
|
QALY
|
Base case
|
300
|
305
|
−866 (-2372;370)
|
0.02 (-0.02;0.05)
|
-50,273
|
8.2
|
76.8
|
12.9
|
2.1
|
Complete cases
|
114
|
98
|
110 (-2004;1611)
|
0.02 (-0.02;0.06)
|
4770
|
46.4
|
40.6
|
4.2
|
8.7
|
|
Health care perspective
|
300
|
305
|
−5 (-316;272)
|
0.02 (-0.02;0.05)
|
−298
|
40.7
|
44.7
|
5.0
|
9.6
|
- ΔC = mean difference in total costs between the intervention group and control group in Euros adjusted to the year 2008; ΔE = mean difference in outcome; ICER is calculated as ΔC/ΔE. ICER, Incremental Cost-Effectiveness Ratio; NE, north-east; SE, south-east; SW, south-west; NW, north-west; T2DM, Type 2 Diabetes Mellitus; CVD, Cardiovascular Disease; QALY, Quality Adjusted Life Years.
-
a The base case analysis and complete case analysis are based on the societal perspective. In the base case analysis and the analysis from the health care perspective missing data were multiply imputed. The complete cases analysis was restricted to participants with complete data on costs and the particular clinical outcome. b NE quadrant: the intervention is more effective and more costly than usual care. c SE quadrant: the intervention is more effective and less costly than usual care. d SW quadrant: the intervention is less effective and less costly than usual care. e NW quadrant: the intervention is less effective and more costly than usual care. f The at the age of 60 anticipated risk for developing T2DM in the following 9 years . g The at the age of sixty anticipated risk of CVD mortality in the following 10 years.